C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

I Huang, R Pranata, MA Lim… - Therapeutic …, 2020 - journals.sagepub.com
Background: Patients critically ill with coronavirus disease-2019 (COVID-19) feature
hyperinflammation, and the associated biomarkers may be beneficial for risk stratification …

[HTML][HTML] Baseline and early changes in laboratory parameters predict disease severity and fatal outcomes in COVID-19 patients

A Gize, Y Belete, M Kassa, W Tsegaye… - Frontiers in Public …, 2023 - frontiersin.org
Introduction Coronavirus disease 2019 (COVID-19) has become the worst catastrophe of the
twenty-first century and has led to the death of more than 6.9 million individuals across the …

Inflammation‐associated factors for predicting in‐hospital mortality in patients with COVID‐19

JH Wang, RD Chen, HK Yang, LC Zeng… - Journal of Medical …, 2021 - Wiley Online Library
The aim is to explore the relation between inflammation‐associated factors and in‐hospital
mortality and investigate which factor is an independent predictor of in‐hospital death in …

[HTML][HTML] Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients

L Sanchez-de Prada, Ó Gorgojo-Galindo… - Frontiers in …, 2022 - frontiersin.org
Background High cytokine levels have been associated with severe COVID-19 disease.
Although many cytokine studies have been performed, not many of them include …

[HTML][HTML] Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis

B Cao, X Jing, Y Liu, R Wen, C Wang - Journal of Thoracic Disease, 2022 - ncbi.nlm.nih.gov
Background This study aimed to summarize the available data on the association between
the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical …

[HTML][HTML] Cytokines from bench to bedside: A retrospective study identifies a definite panel of biomarkers to early assess the risk of negative outcome in COVID-19 …

M Fabris, F Del Ben, E Sozio, AP Beltrami… - International Journal of …, 2022 - mdpi.com
The main aim of this study was to identify the most relevant cytokines which, when assessed
in the earliest stages from hospital admission, may help to select COVID-19 patients with …

[HTML][HTML] Inflammatory markers as predictors of mortality in COVID-19 infection

AA Ahmeidi, A Musa, HS Ahmed, AA Elahmar… - African journal of …, 2020 - scielo.org.za
AAA, AM, AAE and IAA developed the concepts and performed the literature search. MOH
and MA helped to supervise the project. AHA and RBG edited the manuscript. AAA, AHA …

C-reactive protein and clinical outcomes in patients with COVID-19

NR Smilowitz, D Kunichoff, M Garshick… - European heart …, 2021 - academic.oup.com
Background A systemic inflammatory response is observed in coronavirus disease 2019
(COVID-19). Elevated serum levels of C-reactive protein (CRP), a marker of systemic …

Association and predictive value of biomarkers with severe outcomes in hospitalized patients with SARS-CoV-2 infection

R Fernandez-Botran, S Furmanek, RS Ambadapoodi… - Cytokine, 2022 - Elsevier
This study analyzed the levels at admission of biomarkers for their association with and
ability to predict risk of severe outcomes, including admission to the ICU, need for invasive …

Neutrophil/lymphocyte ratio (NLR) and lymphocyte/monocyte ratio (LMR)–risk of death inflammatory biomarkers in patients with COVID-19

V Dymicka-Piekarska, J Dorf, A Milewska… - Journal of …, 2023 - Taylor & Francis
Aim The aim of our retrospective study was search for new prognostic parameters, which
can help quickly and cheaply identify patients with risk for severe course of SARS-CoV-2 …